Answers are grounded in this paper and cite their sources.
Robust predictive models of clinical impairment and worsening in multiple sclerosis (MS) are needed to identify patients at risk and optimize treatment strategies.
No takes yet. Share an insight, caveat, or question.
Noteboom et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: